Closing Thought

Aug 01, 2005
Applied Clinical Trials
By Applied Clinical Trials Editors
The Food and Drug Administration's (FDA) Critical Path Initiative and subsequent guidance documents have sparked the revitalization of the life sciences industry.
Jul 01, 2005
Applied Clinical Trials
By Applied Clinical Trials Editors
Following the model of the home health care industry might be the answer to high subject dropout rates in clinical trials.
Jun 01, 2005
Applied Clinical Trials
Clinical departments are very expensive to run and maintain.
Apr 01, 2005
Applied Clinical Trials
By Applied Clinical Trials Editors
With the advent of personalized medicine and purported "race-based therapies" such as BilDil in the news, it is time the pharmaceutical industry makes a more concerted effort to engage racial and ethnic minority groups and the rural poor in clinical research.
Mar 01, 2005
Applied Clinical Trials
By Applied Clinical Trials Editors
Informed consent takes place in the brain. While that seems obvious, the implications of that statement go much deeper. To a great extent, both bioethics and federal policy are based on 17th century assumptions by philosophers such as Descartes—who knew nothing of the structure and function of the brain.
Feb 01, 2005
Applied Clinical Trials
In the biomedical research industry, and at Pfizer in particular, we are committed to what we call "The Three As"—making medicines available, accessible, and affordable.
Oct 01, 2004
Applied Clinical Trials
By Applied Clinical Trials Editors
We work so hard to recruit subjects for clinical trials, so why don't we try harder to retain them?
native1_300x100
lorem ipsum